Literature DB >> 26471692

MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT Applied for Dosimetry of Radiopharmaceutical Therapy.

Michael Ljungberg1, Anna Celler2, Mark W Konijnenberg3, Keith F Eckerman4, Yuni K Dewaraja5, Katarina Sjögreen-Gleisner6, Wesley E Bolch, A Bertrand Brill, Frederic Fahey, Darrell R Fisher, Robert Hobbs, Roger W Howell, Ruby F Meredith, George Sgouros, Pat Zanzonico, Klaus Bacher, Carlo Chiesa, Glenn Flux, Michael Lassmann, Lidia Strigari, Stephan Walrand.   

Abstract

The accuracy of absorbed dose calculations in personalized internal radionuclide therapy is directly related to the accuracy of the activity (or activity concentration) estimates obtained at each of the imaging time points. MIRD Pamphlet no. 23 presented a general overview of methods that are required for quantitative SPECT imaging. The present document is next in a series of isotope-specific guidelines and recommendations that follow the general information that was provided in MIRD 23. This paper focuses on (177)Lu (lutetium) and its application in radiopharmaceutical therapy.
© 2016 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Entities:  

Keywords:  SPECT/CT; endocrine; guideline; image processing; lutetium; oncology; quantitative SPECT; radiobiology/dosimetry; radionuclide therapy

Mesh：

Substances：

Year:  2015        PMID： 26471692     DOI： 10.2967/jnumed.115.159012

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


  62 in total

Review 1.  SPECT/CT: an update on technological developments and clinical applications.

Authors:  Michael Ljungberg; P Hendrik Pretorius
Journal:  Br J Radiol       Date:  2017-01-16       Impact factor: 3.039

2.  Radiopharmaceutical Therapy.

Authors:  George Sgouros
Journal:  Health Phys       Date:  2019-02       Impact factor: 1.316

3.  First-in-human dosimetry of gastrin-releasing peptide receptor antagonist [177Lu]Lu-RM2: a radiopharmaceutical for the treatment of metastatic castration-resistant prostate cancer.

Authors:  Jens Kurth; Bernd Joachim Krause; Sarah M Schwarzenböck; Carina Bergner; Oliver W Hakenberg; Martin Heuschkel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-09-03       Impact factor: 9.236

4.  Technical Note: Single time point dose estimate for exponential clearance.

Authors:  Mark T Madsen; Yusuf Menda; Thomas M O'Dorisio; M Sue O'Dorisio
Journal:  Med Phys       Date:  2018-04-16       Impact factor: 4.071

5.  Deep-Learning Generation of Synthetic Intermediate Projections Improves 177Lu SPECT Images Reconstructed with Sparsely Acquired Projections.

Authors:  Tobias Rydén; Martijn Van Essen; Ida Marin; Johanna Svensson; Peter Bernhardt
Journal:  J Nucl Med       Date:  2020-08-28       Impact factor: 10.057

Review 6.  What scans we will read: imaging instrumentation trends in clinical oncology.

Authors:  Thomas Beyer; Luc Bidaut; John Dickson; Marc Kachelriess; Fabian Kiessling; Rainer Leitgeb; Jingfei Ma; Lalith Kumar Shiyam Sundar; Benjamin Theek; Osama Mawlawi
Journal:  Cancer Imaging       Date:  2020-06-09       Impact factor: 3.909

7.  A Novel Time-Activity Information-Sharing Approach Using Nonlinear Mixed Models for Patient-Specific Dosimetry with Reduced Imaging Time Points: Application in SPECT/CT After 177Lu-DOTATATE.

Authors:  Theresa P Devasia; Yuni K Dewaraja; Kirk A Frey; Ka Kit Wong; Matthew J Schipper
Journal:  J Nucl Med       Date:  2020-12-18       Impact factor: 10.057

8.  Overview of the First NRG Oncology-National Cancer Institute Workshop on Dosimetry of Systemic Radiopharmaceutical Therapy.

Authors:  Emilie Roncali; Jacek Capala; Stanley H Benedict; Gamal Akabani; Bryan Bednarz; Vikram Bhadrasain; Wesley E Bolch; Jeffrey C Buchsbaum; Norman C Coleman; Yuni K Dewaraja; Eric Frey; Michael Ghaly; Joseph Grudzinski; Robert F Hobbs; Roger W Howell; John L Humm; Charles A Kunos; Steve Larson; Frank I Lin; Mark Madsen; Saed Mirzadeh; David Morse; Daniel Pryma; George Sgouros; Sara St James; Richard L Wahl; Ying Xiao; Pat Zanzonico; Katherine Zukotynski
Journal:  J Nucl Med       Date:  2020-12-04       Impact factor: 10.057

Review 9.  Current Status of Radiopharmaceutical Therapy.

Authors:  Sara St James; Bryan Bednarz; Stanley Benedict; Jeffrey C Buchsbaum; Yuni Dewaraja; Eric Frey; Robert Hobbs; Joseph Grudzinski; Emilie Roncali; George Sgouros; Jacek Capala; Ying Xiao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-08-14       Impact factor: 7.038

10.  Evaluation of Dosimetric Parameters for Tumor Therapy with 177Lu and 90Y Radionuclides in Gate Monte Carlo Code.

Authors:  Milad Peer-Firozjaei; Mohammad Ali Tajik-Mansoury; Raheb Ghorbani; Mahdi Mazinani
Journal:  J Biomed Phys Eng       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.